MRB Discussion Notes - Recommendations Re. FDA Warnings
MRB Discussion Notes - Recommendations Re. FDA Warnings
DOT is committed to ensuring that information is available in appropriate alternative formats to meet the requirements of persons who have a disability. If you require an alternative version of files provided on this page, please contact
MRB@dot.gov.
Last updated: Wednesday, December 14, 2016